Clinical Audit on the Effectiveness of Clinic-Based Intraocular Pressure Phasing for Patients With Glaucoma and Glaucoma Suspect.
clinical audit
diurnal intraocular pressure
glaucoma
intraocular pressure fluctuation
office hour phasing
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
accepted:
28
02
2022
entrez:
7
4
2022
pubmed:
8
4
2022
medline:
8
4
2022
Statut:
epublish
Résumé
Glaucoma is a complex disease with intraocular pressure (IOP) playing an important role in its diagnosis and management. IOP has shown diurnal and nocturnal variations, which may affect the course of the disease. The objective of this study was to determine the effectiveness of clinic-based office hour phasing in the diagnosis and management of glaucoma and glaucoma suspect (GS). A retrospective clinical audit was conducted on patients who were subjected to office hour phasing in a glaucoma clinic, Hospital Universiti Sains Malaysia, Kelantan, Malaysia, between January 2015 and December 2019. The office hour phasing was conducted for various indications such as confirmation of diagnosis, screening, and effectiveness of treatment. IOP was recorded every two hours between 0800 and 1600 using an air puff tonometer by a trained nurse. Measurement of IOP was repeated with Goldmann applanation tonometer at sitting position by a trainee when the IOP ≥ 20 mmHg or discrepancy of IOP > 2 mmHg between two eyes. Other investigations including a Humphrey visual field and gonioscopy were conducted in between the IOP measurements. Diagnosis and clinical decisions on management were made at the end of the office hour clinic phasing. A total of 83 patients (163 eyes) were included in this clinical audit. Their mean age was 59.3 (16.5) years with 59% of male patients. Both eyes showed an almost similar pattern of mean IOP over five daytime readings in the clinic. A total of 35 eyes (21.5%) showed fluctuation ≥ 6 mmHg, and 128 eyes (78.5%) showed stable IOP during the clinic hour phasing. There was a significant difference in the mean IOP pattern between groups with stable and fluctuating IOP based on repetitive measure analysis of variance (RM ANOVA) (p = 0.008). The final diagnosis was made for 39 eyes (21 OD [right eye] and 18 OS [left eye]) out of 131 eyes (29.8%) with GS. Confirmation of diagnosis was achieved in all eyes (100%) with suspected ocular hypertension (OHT) and normal-tension glaucoma (NTG). Progression of glaucoma was confirmed in four eyes (2 OD and 2 OS) out of 17 eyes (23.5%) with suspected progression. Clinic hour IOP phasing provides a practical approach in confirmation of diagnosis and adjustment in the management of patients with glaucoma and GS.
Identifiants
pubmed: 35386148
doi: 10.7759/cureus.22726
pmc: PMC8968089
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e22726Informations de copyright
Copyright © 2022, Nanthini et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Clin Ophthalmol. 2018 Dec 18;13:9-16
pubmed: 30587914
IEEE Trans Biomed Eng. 2013 Jan;60(1):250-6
pubmed: 22736631
J Glaucoma. 2007 Jan;16(1):164-8
pubmed: 17224768
Ophthalmologica. 1998;212(2):115-9
pubmed: 9486551
Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5271-9
pubmed: 26258611
J Ophthalmol. 2016;2016:4727423
pubmed: 27525110
Eye (Lond). 2016 Jun;30(6):784-95
pubmed: 27174381
J Glaucoma. 2007 Mar;16(2):201-4
pubmed: 17473730
Asia Pac J Ophthalmol (Phila). 2019 Nov-Dec;8(6):457-468
pubmed: 31789648
Curr Opin Pharmacol. 2013 Feb;13(1):32-5
pubmed: 23122026
Adv Ther. 2018 Nov;35(11):1775-1804
pubmed: 30341506
Asia Pac J Ophthalmol (Phila). 2016 Jan-Feb;5(1):32-7
pubmed: 26886117
Taiwan J Ophthalmol. 2018 Apr-Jun;8(2):74-81
pubmed: 30038885
Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1851-7
pubmed: 17901971
Graefes Arch Clin Exp Ophthalmol. 2005 Jun;243(6):513-8
pubmed: 15756577
BMJ. 2017 Sep 13;358:j3889
pubmed: 28903935
Br J Ophthalmol. 2010 Aug;94(8):999-1002
pubmed: 19965831
BMC Ophthalmol. 2021 Jun 21;21(1):262
pubmed: 34154547
Br J Ophthalmol. 2011 Apr;95(4):594
pubmed: 21258077
Arch Ophthalmol. 2012 Dec;130(12):1534-9
pubmed: 22892888
Ophthalmic Res. 2020;63(3):295-301
pubmed: 32097919
JAMA Ophthalmol. 2014 Apr 1;132(4):390-5
pubmed: 24481483
Am J Ophthalmol. 1998 Oct;126(4):498-505
pubmed: 9780094
JAMA. 2014 May 14;311(18):1901-11
pubmed: 24825645
J Ophthalmol. 2019 Sep 19;2019:3632197
pubmed: 31641532
Eye (Lond). 2007 Jul;21(7):948-51
pubmed: 16601737
J Glaucoma. 2016 Oct;25(10):807-811
pubmed: 27513898
J Glaucoma. 2003 Jun;12(3):232-6
pubmed: 12782841
Ophthalmology. 2013 Apr;120(4):731-5
pubmed: 23260257